Pharmaceutical Technology's In the Lab eNewsletter
Stream Bio entered into a new agreement with DBA Italia to launch Stream Bio’s nanotech-based bioimaging probes in Italy.
On March 12, 2019, Stream Bio, a developer and manufacturer of innovative bioimaging molecular probes, entered into a new agreement with DBA Italia, a supplier of research reagents for immunology, biochemistry, cellular, and molecular biology, to launch Stream Bio’s nanotech-based bioimaging probes in Italy.
The agreement expands Stream Bio’s European distribution network for its Conjugated Polymer Nanoparticles (CPNs), which represent a new generation of novel molecular bioimaging probes. These nanoparticles are highly fluorescent and non-toxic, offering stability, magnetic capability, and suitability to be conjugated with a wide range of molecules.
The launch highlights the continued growth and commercial potential of the CPNs. Stream Bio also recently received an Innovate UK-funded manufacturing and materials loan, which will enable the further expansion of its product range.
The CPNs come in four emission wavelengths ranging from 475–680 nm and can now be streptavidin-linked. Applications for these probes include diagnostics and therapeutics and the potential to be used for imaging tumors and fluorescence-guided surgery. They are already distributed in the United Kingdom and Ireland through 2BScientific, in France through CliniSciences, and in Germany through Biotrend.
Source: Stream Bio
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
WMFTS’ BioPure to Showcase Single-Use Bioclamp with Refined Manufacturing at INTERPHEX 2025
April 1st 2025With advanced manufacturing, BioPure’s BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.